BioNTech’s updated COVID-19 vaccine that protects against one of the most recently circulating variants of the virus. The ...

Pfizer Canada ULC and BioNTech SE (Nasdaq: BNTX, "BioNTech") announced today that Health Canada has authorized the KP.2 ...

The Department of Health and Human Services will soon restart its program of offering free rapid tests for the virus through ...

These five top stocks trade at reasonable levels and offer the strength that makes sense as we enter a very volatile time of ...

SEPANG: Dr Roland Victor, who is charged with making and initiating the transmission of offensive videos about the Covid-19 ...

The latest strain of the COVID-19 virus, XEC, is circulating across the country. The new variant has been reported in at ...

It’s been over four years since the beginning of the COVID-19 pandemic. And since then, the virus has changed substantially.

Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and ...

The University of Pennsylvania has sued German biotechnology firm BioNTech in Pennsylvania federal court, accusing the ...

Pfizer-BioNTech's updated vaccine to protect against a recently circulating variant of COVID-19 is authorized, Health Canada ...

The mRNA vaccine, called Comirnaty, targets the KP.2 subvariant of Omicron, replacing the previous version which targeted the ...